Evaluating sample stability in the clinical laboratory with the help of linear and non-linear regression analysis

Author:

Pum Joachim K.W.1

Affiliation:

1. Bioscientia Institut für Medizinische Diagnostik GmbH , MVZ Jena , Orlaweg 2 , Jena 07743 , Germany

Abstract

Abstract As it is common practice for laboratories to store patient samples for a predefined period, allowing clinicians to request additional tests on previously collected samples, knowledge about sample stability is indispensable for the laboratorian. A common approach to estimating the maximum storage time is to use a discrete study design, measuring the analyte of interest at various time-points and then checking for significant differences with the help of a statistical test, such as Student’s t-test, Wilcoxon’s test or an analysis of variance (ANOVA) test. Because only discrete time intervals are considered, stability data can just be approximated. Alternatively, a continuous study design, as described by the Clinical and Laboratory Standards Institute (CLSI) for performing stability experiments for in vitro diagnostic reagents, can also be adopted by the clinical laboratory to evaluate the stability of biological samples. The major advantage of this approach is that it allows laboratories to define individual stability limits for different medical situations and offers more flexibility when choosing time-points for measurements. The intent of this paper is to demonstrate the evaluation of sample stability in the clinical laboratory with a continuous study design implemented with linear or non-linear regression analysis. Appropriate statistical modeling and acceptance criteria are presented, stability functions are described briefly, and checking the overall validity of the results is discussed.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Reference50 articles.

1. DIN EN ISO 15189:2014. Medical laboratories – particular requirements for quality and competence. Geneva, Switzerland: International Organization for Standardization, 2014.

2. CAP – All Common Checklist, 08/21/2017 Edition, CAP Accreditation Program. Northfield, IL: College of American Pathologists, 2018.

3. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Immunogenicity testing of therapeutic protein products developing and validating assays for anti-drug antibody detection – Guidance for industry, 2019. https://www.fda.gov/media/119788/download. Accessed: 02 July 2019.

4. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Bioanalytical Method Validation – Guidance for Industry, 2018. https://www.fda.gov/media/70858/download. Accessed: 02 July 2019.

5. Briscoe C. Assessing stability in bioanalysis: reflections on the last 10 years. Bioanalysis 2019;11:579–82.

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3